Johnson & Johnson was honored as one of Fast Company’s top ten most innovative biotech companies. Johnson & Johnson was recognized for its incubation of medical startups. Learn more about the ranking on Fast Company’s
website. Check out
JLABS to learn more about how we support startups.
The condition is typically diagnosed in adults, but research suggests an uptick in adolescent patients. Learn more about the rare autoantibody disease, how one teen is managing it and why Johnson & Johnson is working to improve treatment options for patients of all ages.
From rare diseases to all-too-common cancers, Johnson & Johnson is on a mission to improve treatment options for people around the globe. Learn more about how the company is working to create new therapies for IBD, lung cancer, major depressive disorder, bladder cancer, myasthenia gravis and more.